Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing and provides cardiovascular and cerebrovascular drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs and anti-infective drugs. The Company's main products include Xuesetong dispersible tablets, Xuesetong tablets, Garcinia bone-strengthening tablets, Dieda Huoxue capsules, Lysine Vitamin B12 granules, Cefuroxime tablets, Jinying capsules, Pudilan anti-inflammatory tablets, Xiaoer Jingxing cough granules, Ezetimibe tablets, Xuanqi bone-strengthening tablets, Qiangli Loquat Paste (honey-refined), Qiangli Loquat Dew and others. It also offers other businesses such as medical services, pharmaceutical commerce and drug sales. The company was founded in 2002 and is based in Changsha, China.
Metrics to compare | 603998 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship603998PeersSector | |
---|---|---|---|---|
P/E Ratio | 18.8x | 31.3x | −0.5x | |
PEG Ratio | 0.43 | −0.42 | 0.00 | |
Price/Book | 3.1x | 3.1x | 2.6x | |
Price / LTM Sales | 2.9x | 4.9x | 3.3x | |
Upside (Analyst Target) | 7.0% | 23.4% | 38.7% | |
Fair Value Upside | Unlock | −2.5% | 5.0% | Unlock |